Nasdaq
$2.44▲ 0.83%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.3MShares out 0.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
18- 10.13Regular26.10.14 03:053Ownership#●●●
Autonomix Medical, Inc.
Sandra C. Kalter of Autonomix Medical, Inc. has filed a Power of Attorney appointing Brad Hauser and Trent Smith as her attorneys-in-fact to handle filings required under Section 16 of the Securities Exchange Act. This filing formalizes the administrative process for reporting the insider's equity holdings and transactions.…more
$2.44+0.83%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.21Pre-market26.09.21 21:134Ownership
Autonomix Medical, Inc.
Insider Trent N. Smith of Autonomix Medical, Inc. has filed a Form 4 to report changes in his beneficial ownership of company securities. This filing serves as the official disclosure of the insider's equity position.…more
$2.44+0.83%vs prev closeView filingShare - 9.16After-hours26.09.17 06:02424B3Offering
Autonomix Medical, Inc.
Autonomix Medical has registered the resale of up to 1,071,826 shares of common stock issuable upon the exercise of new Series E warrants issued in connection with a warrant inducement transaction. The company could receive up to approximately $6.7 million in gross proceeds if all warrants are exercised for cash, though the timing and occurrence of such exercises remain uncertain. Additionally, the company completed a 1:21 reverse stock split on June 24, 2026.…more
$2.44+0.83%vs prev closeView filingShare
17 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.2Pre-market26.10.02 21:05#●●●#●●●
Autonomix Medical Strengthens Patent Protection for Platform Technology…more
Autonomix Medical has secured a new Canadian patent for its catheter-based nerve-targeted treatment technology, expanding its global intellectual property portfolio. While this strengthens the company's competitive moat, it does not represent immediate revenue generation.…more
$2.44+0.83%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.2Pre-market26.10.02 21:06
●●●●●●●● ●●●●● ●●●●●●
Surrozen has received FDA clearance for its IND application for SZN-8141 to treat diabetic macular edema. This milestone triggers the second tranche of a private placement, providing approximately $95.1 million in capital.…more
$2.44+0.83%vs prev closeShareBenzinga - 9.30Pre-market26.09.30 21:32
●●●●●●●● ●●●●● ●●●●●●
Autonomix Medical has successfully completed a pre-submission meeting with the FDA regarding its transvascular sensing platform. The company identified a Class II regulatory pathway and aims for U.S. clearance in approximately 15 months.…more
$2.44+0.83%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report